Following each of the past four initial rate hikes since 1990, the consumer discretionary sector on average underperformed the broader S&P. What holds up? What pulls the sector lower, and what do analysts expect this time around?» Read More
Transports have had a really rough year, with the Dow Transports down more than 11 percent. What does it say about the economy – and are there buying opportunities amid the broader selloff?
Many industrial names are influenced by global growth, particularly in emerging markets. Morgan Brennan breaks down the industrial companies with large EM exposure and it means for the stocks as earnings season gets underway.
Prescription drug prices are out of control, but there's a way to make your money back: The drugstore stocks are very healthy right now.
Investors are bailing out of high-yield bonds, spreads are widening and prices are falling as the global economic picture deteriorates.
The legendary investment sage gives advice on how to keep nerves in check, and take advantage of opportunities during a market correction.
The biggest fear for many investors has been a Fed rate hike crushing bond values, but with stocks in correction, bonds look pretty good now.
Consumer-discretionary stocks had been outperforming the S&P 500 by a long shot but that looks like it's ending now. Here's why.
Fed, take note: Weak earnings from the nation's largest retailer signal the weakness in wages and consumer spending.
For three consecutive years, stock dividends have grown by 10 percent or more, but it's looking like the record run will end, S&P predicts.
Americans like to eat, drink and ... buy organic. You can see those habits paying off—at least for some consumer staples stocks.
California may be thirsting for more drops of water, but water utilities in the state—and elsewhere—are doing great.
The Netflix series 'Marco Polo' was considered a flop. But there was a good reason for Netflix to make the series, after all: China.
Utilities want to extend the operating licenses of nuclear plants to as long as 80 years, in part spurred by President Obama's coal policy.
The Aetna and Humana tie-up promises to impact consumers, hospitals and doctors as the companies look for ways to cut costs.
While much of the attention has been orbiting SpaceX, analysts say investors should explore its more diversified competitors.
A big question in Silicon Valley is what will happen to all the unicorns. An athlete's stats after a big contract may offer an answer.
CNBC's Morgan Brennan finds bargains in the outperforming biotech sector.
The health-care sector is hot, and investors don't have to bet on the riskiest biotech stocks to profit.
Since 1990 this stock sector has risen 5.2 percent. It's outperformed the broader market 65 percent of the time from May to October.
In terms of deal value, healthcare has logged the most M&A activity this year, according to Dealogic, after taking the top spot in both 2014 and 2013. CNBC's Morgan Brennan reports.